BMO Capital Maintains Outperform on Morgan Stanley, Lowers Price Target to $215

Benzinga Newsdesk www.benzinga.com Negative 94.8%

Neg 94.8% Neu 0% Pos 0%

BMO Capital analyst Brennan Hawken maintains Morgan Stanley (NYSE:MS) with a Outperform and lowers the price target from $250 to $215.